Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
American Heart Association
MedTech
Boston Scientific, Abbott tout long-term heart occluder data
Boston Scientific and Abbott both put forward studies supporting their respective implants for sealing off the heart’s left atrial appendage.
Conor Hale
Nov 19, 2024 12:00pm
Ablation before meds shows gains in v-tach after heart attack
Nov 18, 2024 11:45am
AI spots high blood pressure, diabetes in slow-motion video
Nov 18, 2024 11:30am
Wireless pacemakers for kids show promise, but challenges remain
Apr 12, 2023 10:00am
AHA: Wearables severely underused by those with heart disease
Oct 31, 2022 11:58am
Mineralys hauls in $118M series B to advance hypertension med
Jun 8, 2022 8:00am
